55 North Private Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
55 North Private Wealth's VRTX Position: Q2 2026 in Review
55 North Private Wealth increased its Vertex Pharmaceuticals (VRTX) stake by 3.8% in Q2 2026, buying an estimated $7.98K and bringing the position to 487 shares worth $242K. The position accounts for 0.05% of the portfolio, ranked #228.
55 North Private Wealth first reported a position in VRTX in Q1 2026 and has held it in 2 quarters since. 1,743 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- 55 North Private Wealth held 487 shares of Vertex Pharmaceuticals worth $242K as of Q2 2026.
- 55 North Private Wealth bought 18 Vertex Pharmaceuticals shares in Q2 2026, an estimated $7.98K.
- Vertex Pharmaceuticals made up 0.05% of 55 North Private Wealth's portfolio in Q2 2026, its #228 holding.
- 55 North Private Wealth first reported a position in Vertex Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
- 1,743 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on 55 North Private Wealth's 13F filing for Q2 2026, filed 7 Jul 2026.